Simian iPS-derived hepatocytes support Plasmodium cynomolgi infection and hypnozoite formation
Frontiers in Cellular and Infection Microbiology · 14.08.2026 · 16
DOI: 10.3389/fcimb.2026.1871289 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 14.08.2026. Verfasst von Mélanie Pellisson und 11 weiteren Autor:innen. Beteiligte Einrichtung: Swiss Tropical and Public Health Institute (Swiss TPH), Allschwil, Switzerland. Hauptthemen laut MEDLINE: Hepatocytes, Plasmodium cynomolgi, Sporozoites, Malaria. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medicines for Malaria Venture, Bill and Melinda Gates Foundation.
Abstract (Originalsprache)
Introduction
Plasmodium cynomolgi is one of the few malaria parasite species that forms dormant liver stages known as hypnozoites and is therefore a suitable model for Plasmodium vivax , the causative agent of recurrent malaria. Very little is known about the biology and pharmacology of liver stage dormancy, which hampers the search for compounds with anti-hypnozoite activity.
Methods
We present the development of a P. cynomolgi in vitro infection model using stem cell-derived hepatocyte-like cells from Macaca fascicularis. iPS cells were established on feeder free condition and differentiated into hepatocyte-like cells via inducible overexpression of key transcription factors.
Results
The generated cells were infected with P. cynomolgi sporozoites, and hypnozoite formation as well as schizont development were confirmed by immunofluorescence microscopy.
Discussion
This simian iPS-derived model is a promising alternative to current P. vivax in vitro infection systems to study the mechanisms underlying liver stage dormancy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Swiss Tropical and Public Health Institute (Swiss TPH), Allschwil, Switzerland.
- University of Basel, Basel, Switzerland.
- Novartis Institutes for Biomedical Research, Novartis Pharma AG, Basel, Switzerland.
- Department of Parasitology, Biomedical Primate Research Centre, Rijswijk, Netherlands.
- Novartis Institute for Tropical Diseases, Novartis Pharma AG, Emeryville, CA, United States.
Förderung
- Medicines for Malaria Venture
- Bill and Melinda Gates Foundation
Zitieren
APA
Pellisson, M., Zeeman, A. M., Doll, T., Kirchhofer-Allan, L., Schuierer, S., Roma, G., Flannery, E. L., Mikolajczak, S., Kocken, C. H. M., Mäser, P., Rottmann, M., & Müller, M. (2026). Simian iPS-derived hepatocytes support Plasmodium cynomolgi infection and hypnozoite formation. Frontiers in Cellular and Infection Microbiology, 16. https://doi.org/10.3389/fcimb.2026.1871289
Vancouver
Pellisson M, Zeeman AM, Doll T, Kirchhofer-Allan L, Schuierer S, Roma G, et al. Simian iPS-derived hepatocytes support Plasmodium cynomolgi infection and hypnozoite formation. Frontiers in Cellular and Infection Microbiology. 2026;16. doi:10.3389/fcimb.2026.1871289
BibTeX
@article{Pellisson2026,
author = {Pellisson, Mélanie and Zeeman, Anne-Marie and Doll, Thierry and Kirchhofer-Allan, Lucy and Schuierer, Sven and Roma, Guglielmo and Flannery, Erika L and Mikolajczak, Sebastian and Kocken, Clemens H M and Mäser, Pascal and Rottmann, Matthias and Müller, Matthias},
title = {Simian iPS-derived hepatocytes support Plasmodium cynomolgi infection and hypnozoite formation},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2026},
volume = {16},
doi = {10.3389/fcimb.2026.1871289}
}
EUVIMED